Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 2603219, 11 pages
http://dx.doi.org/10.1155/2016/2603219
Research Article

Longxuetongluo Capsule Improves Erythrocyte Function against Lipid Peroxidation and Abnormal Hemorheological Parameters in High Fat Diet-Induced ApoE−/− Mice

1Modern Research Center for Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China
2School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China
3Hemorheology Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China
4National Key Laboratory of Pharmaceutical New Technology for Chinese Medicine, Jiangsu Kanion Pharmaceutical Co. Ltd., Lianyungang 222001, China

Received 18 April 2015; Revised 10 July 2015; Accepted 12 July 2015

Academic Editor: Cinzia Signorini

Copyright © 2016 Jiao Zheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. H. Jay, S. N. McCarthy, M. W. Rampling, and D. J. Betteridge, “Blood rheology and fibrinogen in children with familial hypercholesterolaemia,” Atherosclerosis, vol. 91, no. 1-2, pp. 117–121, 1991. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Schechner, R. Ben-Ami, T. Hershcovici et al., “Plasma dependent reduction in red blood cell aggregation after dextran sulfate low-density lipoprotein apheresis—implications for rheological studies,” Therapeutic Apheresis and Dialysis, vol. 9, no. 5, pp. 379–384, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Kanakaraj and M. Singh, “Influence of hypercholesterolemia on morphological and rheological characteristics of erythrocytes,” Atherosclerosis, vol. 76, no. 2-3, pp. 209–218, 1989. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Leonhardt, H.-R. Arntz, and U. H. Klemens, “Studies of plasma viscosity in primary hyperlipoproteinaemia,” Atherosclerosis, vol. 28, no. 1, pp. 29–40, 1977. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Koter, I. Franiak, K. Strychalska, M. Broncel, and J. Chojnowska-Jezierska, “Damage to the structure of erythrocyte plasma membranes in patients with type-2 hypercholesterolemia,” The International Journal of Biochemistry and Cell Biology, vol. 36, no. 2, pp. 205–215, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Uyuklu, H. J. Meiselman, and O. K. Baskurt, “Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties,” Clinical Hemorheology and Microcirculation, vol. 36, no. 1, pp. 25–33, 2007. View at Google Scholar · View at Scopus
  7. A. Vayá, M. Martínez Triguero, E. Réganon et al., “Erythrocyte membrane composition in patients with primary hypercholesterolemia,” Clinical Hemorheology and Microcirculation, vol. 40, no. 4, pp. 289–294, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Krokosz, J. Grebowski, Z. Szweda-Lewandowska, A. Rodacka, and M. Puchala, “Can melatonin delay oxidative damage of human erythrocytes during prolonged incubation,” Advances in Medical Sciences, vol. 58, no. 1, pp. 134–142, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Karuna, S. Reddy, R. Baskar, and D. Saralakumari, “Antioxidant potential of aqueous extract of Phyllanthus amarus in rats,” Indian Journal of Pharmacology, vol. 41, no. 2, pp. 64–67, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Zheng, X. Wang, H. Li, Y. Gu, P. Tu, and Z. Wen, “Improving abnormal hemorheological parameters in ApoE-/- mice by Ilex kudingcha total saponins,” Clinical Hemorheology and Microcirculation, vol. 42, no. 1, pp. 29–36, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Xu, Y. Zhang, Y. Lei et al., “A systems biology-based approach to uncovering the molecular mechanisms underlying the effects of dragon's blood tablet in colitis, involving the integration of chemical analysis, ADME prediction, and network pharmacology,” PLoS ONE, vol. 9, no. 7, Article ID e101432, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Masaoud, H. Ripperger, A. Porzel, and G. Adam, “Flavonoids of dragon's blood from Dracaena cinnabari,” Phytochemistry, vol. 38, no. 3, pp. 745–749, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. C.-S. Choy, C.-M. Hu, W.-T. Chiu et al., “Suppression of lipopolysaccharide-induced of inducible nitric oxide synthase and cyclooxygenase-2 by Sanguis Draconis, a dragon's blood resin, in RAW 264.7 cells,” Journal of Ethnopharmacology, vol. 115, no. 3, pp. 455–462, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Zhu, P. Zhang, H. Yu, J. Li, M.-W. Wang, and W. Zhao, “Anti-Helicobacter pylori and thrombin inhibitory components from Chinese dragon's blood, Dracaena cochinchinensis,” Journal of Natural Products, vol. 70, no. 10, pp. 1570–1577, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Xin, Y.-J. Li, Y. Li et al., “Dragon's Blood extract has antithrombotic properties, affecting platelet aggregation functions and anticoagulation activities,” Journal of Ethnopharmacology, vol. 135, no. 2, pp. 510–514, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Yi, H.-B. Chen, Z.-Z. Zhao, Z.-L. Yu, and Z.-H. Jiang, “Comparison of the chemical profiles and anti-platelet aggregation effects of two ‘dragon's Blood’ drugs used in traditional Chinese medicine,” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 796–802, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Gupta and R. K. Gupta, “Bioprotective properties of Dragon's blood resin: in vitro evaluation of antioxidant activity and antimicrobial activity,” BMC Complementary and Alternative Medicine, vol. 11, article 13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Ran, R. Wang, Q. Gao et al., “Dragon's blood and its extracts attenuate radiation-induced oxidative stress in mice,” Journal of Radiation Research, vol. 55, no. 4, pp. 699–706, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. P. F. Tu, W. Xiao, Y. Q. Hu et al., “New process for preparing total flavone of Dracaena cochinchinensis and its new application,” Faming Zhuanli Shenqing, CN 1482124 A 20040317, 2004.
  20. W. Xiao, P. F. Tu, Z. Z. Wang et al., “Quality control method of medicinal preparation containing resins from Dracaena cochinchinensis,” Faming Zhuanli Shenqing, CN 101780190 A 20100721, 2010.
  21. W. Xiao, P. F. Tu, Z. Z. Wang et al., “Quality control method of extract of resins from Dracaena cochinchinensis,” Faming Zhuanli Shenqing, CN 101780191 A 20100721, 2010.
  22. X.-Q. Su, Y.-L. Song, J. Zhang et al., “Dihydrochalcones and homoisoflavanes from the red resin of Dracaena cochinchinensis (Chinese dragon's blood),” Fitoterapia, vol. 99, no. 1, pp. 64–71, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. X.-Q. Su, M.-M. Li, Y.-F. Gu et al., “Phenolic constituents from draconis resina,” Chinese Traditional and Herbal Drugs, vol. 45, no. 11, pp. 1511–1514, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. M. S. Hammes, S. Watson, F. L. Coe, F. Ahmed, E. Beltran, and P. Dhar, “A symmetric dimethylarginine and whole blood viscosity in renal failure,” Clinical Hemorheology and Microcirculation, vol. 59, no. 3, pp. 245–255, 2015. View at Google Scholar
  25. J. Detterich, T. Alexy, M. Rabai et al., “Low-shear red blood cell oxygen transport effectiveness is adversely affected by transfusion and further worsened by deoxygenation in sickle cell disease patients on chronic transfusion therapy,” Transfusion, vol. 53, no. 2, pp. 297–305, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. Z.-Y. Wen, L.-C. Song, Z.-Y. Yan et al., “An animal model to study erythrocyte senescence with a narrow time window of erythrocyte production: alterations in osmotic fragility and deformability of erythrocytes during their life span,” Clinical Hemorheology and Microcirculation, vol. 19, no. 4, pp. 299–306, 1998. View at Google Scholar · View at Scopus
  27. M. L. G. Bautista, W. Altaf, R. Lall, and R. A. Wapnir, “Cord blood red cell osmotic fragility: a comparison between preterm and full-term newborn infants,” Early Human Development, vol. 72, no. 1, pp. 37–46, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. L. C. S. Medeiros, W. D. Souza, C. Jiao, H. Barrabin, and K. Miranda, “Visualizing the 3D architecture of multiple erythrocytes infected with plasmodium at nanoscale by focused ion beam-scanning electron microscopy,” PLoS ONE, vol. 7, no. 3, Article ID e33445, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. H. A. Uydu, S. Yıldırmış, C. Örem et al., “The effects of atorvastatin therapy on rheological characteristics of erythrocyte membrane, serum lipid profile and oxidative status in patients with dyslipidemia,” Journal of Membrane Biology, vol. 245, no. 11, pp. 697–705, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Debaugnies, F. Cotton, C. Boutique, and B. Gulbis, “Erythrocyte membrane protein analysis by sodium dodecyl sulphate-capillary gel electrophoresis in the diagnosis of hereditary spherocytosis,” Clinical Chemistry and Laboratory Medicine, vol. 49, no. 3, pp. 485–492, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. H. R. Davis and E. P. Veltri, “Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia,” Journal of Atherosclerosis and Thrombosis, vol. 14, no. 3, pp. 99–108, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. V. S. Rao, R. K. Nagaraj, S. Hebbagodi, N. B. Kadarinarasimhiah, and V. V. Kakkar, “Association of inflammatory and oxidative stress markers with metabolic syndrome in Asian Indians in India,” Cardiology Research and Practice, vol. 2011, Article ID 295976, 8 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. O. Hussein, L. L. Minasian, Y. Itzkovich, K. Shestatski, L. Solomon, and J. Zidan, “Ezetimibe's effect on platelet aggregation and LDL tendency to peroxidation in hypercholesterolaemia as monotherapy or in addition to simvastatin,” British Journal of Clinical Pharmacology, vol. 65, no. 5, pp. 637–645, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. C.-J. Tai, C.-H. Chen, H.-H. Chen, and H.-J. Liang, “Differential effect of high dietary fat intakes on haemorheological parameters in rats,” British Journal of Nutrition, vol. 103, no. 7, pp. 977–983, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. Z.-Y. Wen, Z.-Y. Yan, T. Gao et al., “A study of effects of WGA and ConA on RBC membrane receptors using a new ektacytometric method,” Clinical Hemorheology and Microcirculation, vol. 17, no. 6, pp. 467–478, 1997. View at Google Scholar · View at Scopus
  36. P. Miossec, F. Zkhiri, J. Pariès, M. David-Dufilho, M. A. Devynck, and P. E. Valensi, “Effect of pravastatin on erythrocyte rheological and biochemical properties in poorly controlled Type 2 diabetic patients,” Diabetic Medicine, vol. 16, no. 5, pp. 424–430, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Perrone, M. L. Tataranno, G. Stazzoni, A. del Vecchio, and G. Buonocore, “Oxidative injury in neonatal erythrocytes,” The Journal of Maternal-Fetal and Neonatal Medicine, vol. 25, no. 5, pp. 104–108, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. L. M. Snyder, N. L. Fortier, J. Trainor et al., “Effect of hydrogen peroxide exposure on normal human erythrocyte deformability, morphology, surface characteristics, and spectrin-hemoglobin cross-linking,” Journal of Clinical Investigation, vol. 76, no. 5, pp. 1971–1977, 1985. View at Publisher · View at Google Scholar · View at Scopus
  39. A. H. Seplowitz, S. Chien, and F. R. Smith, “Effects of lipoproteins on plasma viscosity,” Atherosclerosis, vol. 38, no. 1-2, pp. 89–95, 1981. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Chien, “Blood rheology in myocardial infarction and hypertension,” Biorheology, vol. 23, no. 6, pp. 633–653, 1986. View at Google Scholar · View at Scopus
  41. R. S. Rosenson and G. D. O. Lowe, “Effects of lipids and lipoproteins on thrombosis and rheology,” Atherosclerosis, vol. 140, no. 2, pp. 271–280, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. D. V. Godin, F. G. Herring, and P. J. M. MacLeod, “Malignant hyperthermia: characterization of erythrocyte membranes from individuals at risk,” Journal of Medicine, vol. 12, no. 1, pp. 35–49, 1981. View at Google Scholar · View at Scopus
  43. C. S. Seibert, M. L. Santoro, D. V. Tambourgi et al., “Lonomia obliqua (Lepidoptera, Saturniidae) caterpillar bristle extract induces direct lysis by cleaving erythrocyte membrane glycoproteins,” Toxicon, vol. 55, no. 7, pp. 1323–1330, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Hayette, D. Dhermy, M.-E. Dos Santos et al., “A deletional frameshift mutation in protein 4.2 gene (allele 4.2 Lisboa) associated with hereditary hemolytic anemia,” Blood, vol. 85, no. 1, pp. 250–256, 1995. View at Google Scholar · View at Scopus
  45. C. Baloyi, F. Khosa, S. Tembani, and K. H. Erlwanger, “The osmotic fragility of erythrocytes from Pekin ducks deprived of water for 24 hours,” South African Journal of Science, vol. 102, no. 1-2, pp. 19–20, 2006. View at Google Scholar · View at Scopus
  46. C. S. Seibert, A. M. Tanaka-Azevedo, M. L. Santoro et al., “Purification of a phospholipase A2 from Lonomia obliqua caterpillar bristle extract,” Biochemical and Biophysical Research Communications, vol. 342, no. 4, pp. 1027–1033, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Suhail, “Antioxidant vitamins and lipoperoxidation in non-pregnant, pregnant, and gestational diabetic women: erythrocytes osmotic fragility profiles,” Journal of Clinical Medicine Research, vol. 2, no. 6, pp. 266–273, 2010. View at Publisher · View at Google Scholar
  48. J. Delaunay, “The molecular basis of hereditary red cell membrane disorders,” Blood Reviews, vol. 21, no. 1, pp. 1–20, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Labios, M. Martínez, A. Vayá, F. Gabriel, V. Guiral, and J. Aznar, “Effect of a modified fibrate (Biniwas Retard) on hemorheological alterations in hyperlipemic patients,” Clinical Hemorheology and Microcirculation, vol. 21, no. 2, pp. 79–85, 1999. View at Google Scholar · View at Scopus
  50. P. Lijnen, D. Echevaría-Vázquez, and V. Petrov, “Influence of cholesterol-lowering on plasma membrane lipids and function,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 18, no. 2, pp. 123–136, 1996. View at Google Scholar · View at Scopus
  51. G. Caimi, R. L. Presti, M. Montana et al., “Lipid peroxidation, nitric oxide metabolites, and their ratio in a group of subjects with metabolic syndrome,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 824756, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus